---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020072"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2025-10-29T23:59:59+00:00"
generated_at: "2026-05-17T01:38:26.137113+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Glucotrack adds Dr. Usman Latif to clinical advisory team for integrated glucose monitoring

## Summary
- Appoints Usman Latif, MD, MBA, a neuromodulation and PDN expert, to its clinical advisory team.
- Dr. Latif is Associate Professor at Kansas University Medical Center and board-certified anesthesiologist.
- Company aims to integrate glucose sensing into spinal cord stimulator leads for PDN patients.
- PDN affects ~1 in 5 Americans with diabetes, over 7 million people.
- Long-term preclinical study completed showing feasibility and safety of epidural glucose monitoring.

## SEC filing metadata
- accession: 0001493152-25-020072
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2025-10-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315225020072/0001493152-25-020072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315225020072/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020072
- JSON: https://secwatch.observer/filing/0001493152-25-020072.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.